Red cell transfusion in the critically ill patient by unknown
POSTER PRESENTATION Open Access
Red cell transfusion in the critically ill patient
L Kersan1, M McGarvey1, C MacNeil1, A Mackay1, K McDowall1, R Ahmed2*
From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
It has been more than a decade since the TRICC trial
established the concept of restrictive transfusion. The
CRIT study subsequently showed that RBC transfusion
may be an independent predictor of worse outcome. We
undertook an audit to determine how our practice com-
pares to the current evidence.
Methods
All ICU patients in the Victoria Infirmary receiving red
blood cells between January 2013 and January 2014
were identified. The haemoglobin transfusion trigger
was obtained from our clinical information system. The
presence of bleeding, severe sepsis, ischaemic heart dis-
ease and traumatic brain injury were determined from
our intensive care patient database and transfusion
request forms.
Results
Red blood cells were issued a total of 124 times during
the study period. In only 15 (12%) instances was the Hb
trigger < 70g/L. The remaining 109 (88%) units trans-
fused were at a Hb >70g/L. Within this high transfusion
trigger group, there were 52 (48%) cases of bleeding, 67
(61%) cases of severe sepsis, 28 (26%) cases of ischaemic
heart disease and 2 (2%) cases of traumatic brain injury.
This left only 15 (12%) occasions where there appeared
to be no clear justification for the decision to transfuse.
Conclusions
Despite the well recognized Hb trigger of 70g/L, there
has been ambiguity regarding transfusion triggers in cer-
tain patients. New evidence is emerging to support
restrictive transfusion in acute upper GI bleeding [1],
septic shock [2] and traumatic brain injury [3]. Only 12%
in our audit had no clear justification for transfusion but
it is arguable that a restrictive strategy should have been
used in these subgroups. Of note, 19 cases of severe sep-
sis also had coexisting coronary artery disease as did
8 cases of bleeding which were not limited to upper GI
bleeding. In addition much of the evidence is so recent
that it predates our audit but there is certainly a need for
increased awareness of these new trials.
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